Market Overview:
The global cefepime injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of hospital-acquired infections (HAIs) and rising demand for cefepime injections due to their high efficacy against a wide range of pathogens. Based on type, the global cefepime injection market can be segmented into 1g/50ml and 2g/100ml segments. The 1g/50ml segment is expected to account for a larger share of the global cefepime injection market than the 2g/100ml segment during the forecast period. This can be attributed to its lower price point as compared with 2g/100ml formulations and growing preference for parenteral drugs over oral drugs among patients hospitalized with HAIs. Based on application, the global cefepime injection market can be divided into hospital, clinics, and recovery center segments.
Product Definition:
A cephalosporin (SEF-a-low-spo-rin) antibiotic. Cefepime is used to treat a wide variety of infections, including pneumonia, meningitis, and sepsis. It is also given before surgery to prevent infection.
1g/50ml:
1g/50ml is the concentration of cephalosporin used for the treatment of bacterial meningitis and epiglottitis. It's usage in treating these diseases has been approved by FDA as well as by EMA, hence it has become a standard drug product. The growth factor in this market is increasing due to presence of various pipeline drugs which are expected to be launched over the forecast period. Some prominent players operating in this segment are Cephalon Inc.
2g/100ml:
2g/100ml is a concentration used for the preparation of cephalosporin antibiotics. It is also known as Cephalosporin (CEP) Injection. 2g/100ml concentration contains 200 mg of cephalosporin and 10 ml of sterile water for injection purposes.
Application Insights:
The hospital application segment led the global market in 2017. The segment will expand further at a steady growth rate over the forecast period. Cefepime is widely used for treating various bacterial infections, including complicated skin and wound infections, osteomyelitis, respiratory tract infections, and UTI among others. It is also used for prophylaxis against such diseases in hospitalized patients to prevent their spread to other individuals with whom they may come into contact during treatment or subsequent visits.
Cefepime has been found effective against multidrug-resistant (MDR) bacteria including MRSA that are resistant to several antibiotics such as methicillin, oxacillin and cloxacillin among others.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending in this region are some factors responsible for its large share. Moreover, increasing incidence of multi-drug resistant tuberculosis is one of the major reasons responsible for cefepime sales to increase significantly in North America.
Asia Pacific is expected to be the fastest growing regional market over the forecast period owing to rising government initiatives and investments on improving public health infrastructure along with an increase in expenditure on medicines and vaccines by governments as a preventive measure against drug-resistant infections. Furthermore, economic development coupled with improvement in living standards has led people from low and middle income countries including India and China to adopt unhealthy lifestyles which increases susceptibility towards infectious diseases such as tuberculosis resulting into increased demand for antibiotics such as cefepime injection over time.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) and rising demand for cephalosporins for the treatment of HAIs
- Growing number of cephalosporin prescriptions due to increasing awareness about the benefits of cephalosporins over other antibiotics
- Rising prevalence of multidrug-resistant bacteria (MDRB) and increasing demand for fourth-generation cephalosporins such as Cefepime Injection to treat MDRB infections
- Increasing use of Cefepime Injection in intensive care units (ICUs) and other critical care settings due to its broad spectrum activity, favorable safety profile, and ease of administration
- Launch of new generic versionsof Cefepime Injection by various manufacturers that will help reduce its cost
Scope Of The Report
Report Attributes
Report Details
Report Title
Cefepime Injection Market Research Report
By Type
1g/50ml, 2g/100ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Pfizer, B Braun, Baxter, Apotex, Fresenius Kabi, Meitheal Pharmaceuticals, Samson Medical Technologies, Sagent, Sandoz, WG Critical Care, Nanjing Hicin Pharmaceutical, Luoxin Group, Guangzhou Baiyunshan Pharmaceutical, Yuekang Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Cefepime Injection Market Report Segments:
The global Cefepime Injection market is segmented on the basis of:
Types
1g/50ml, 2g/100ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- B Braun
- Baxter
- Apotex
- Fresenius Kabi
- Meitheal Pharmaceuticals
- Samson Medical Technologies
- Sagent
- Sandoz
- WG Critical Care
- Nanjing Hicin Pharmaceutical
- Luoxin Group
- Guangzhou Baiyunshan Pharmaceutical
- Yuekang Pharmaceutical Group
Highlights of The Cefepime Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1g/50ml
- 2g/100ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cefepime Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cefepime injection is a medication used to treat infections caused by bacteria, such as pneumonia. It works by stopping the growth of the bacteria.
Some of the major companies in the cefepime injection market are Pfizer, B Braun, Baxter, Apotex, Fresenius Kabi, Meitheal Pharmaceuticals, Samson Medical Technologies, Sagent, Sandoz, WG Critical Care, Nanjing Hicin Pharmaceutical, Luoxin Group, Guangzhou Baiyunshan Pharmaceutical, Yuekang Pharmaceutical Group.
The cefepime injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cefepime Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cefepime Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cefepime Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cefepime Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cefepime Injection Market Size & Forecast, 2020-2028
4.5.1 Cefepime Injection Market Size and Y-o-Y Growth
4.5.2 Cefepime Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1g/50ml
5.2.2 2g/100ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cefepime Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cefepime Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1g/50ml
9.6.2 2g/100ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1g/50ml
10.6.2 2g/100ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1g/50ml
11.6.2 2g/100ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1g/50ml
12.6.2 2g/100ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1g/50ml
13.6.2 2g/100ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cefepime Injection Market: Competitive Dashboard
14.2 Global Cefepime Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 B Braun
14.3.3 Baxter
14.3.4 Apotex
14.3.5 Fresenius Kabi
14.3.6 Meitheal Pharmaceuticals
14.3.7 Samson Medical Technologies
14.3.8 Sagent
14.3.9 Sandoz
14.3.10 WG Critical Care
14.3.11 Nanjing Hicin Pharmaceutical
14.3.12 Luoxin Group
14.3.13 Guangzhou Baiyunshan Pharmaceutical
14.3.14 Yuekang Pharmaceutical Group
